Paper and Flexible Substrates as Materials for Biosensing Platforms to Detect Multiple Biotargets
View/ Open
Author
Asghar, Waseem
Inci, Fatih
Yuksekkaya, Mehmet
Jahangir, Muntasir
Zhang, Michael H.
Durmus, Naside Gozde
Gurkan, Umut Atakan
Published Version
https://doi.org/10.1038/srep08719Metadata
Show full item recordCitation
Shafiee, Hadi, Waseem Asghar, Fatih Inci, Mehmet Yuksekkaya, Muntasir Jahangir, Michael H. Zhang, Naside Gozde Durmus, Umut Atakan Gurkan, Daniel R. Kuritzkes, and Utkan Demirci. 2015. “Paper and Flexible Substrates as Materials for Biosensing Platforms to Detect Multiple Biotargets.” Scientific Reports 5 (1): 8719. doi:10.1038/srep08719. http://dx.doi.org/10.1038/srep08719.Abstract
The need for sensitive, robust, portable, and inexpensive biosensing platforms is of significant interest in clinical applications for disease diagnosis and treatment monitoring at the point-of-care (POC) settings. Rapid, accurate POC diagnostic assays play a crucial role in developing countries, where there are limited laboratory infrastructure, trained personnel, and financial support. However, current diagnostic assays commonly require long assay time, sophisticated infrastructure and expensive reagents that are not compatible with resource-constrained settings. Although paper and flexible material-based platform technologies provide alternative approaches to develop POC diagnostic assays for broad applications in medicine, they have technical challenges integrating to different detection modalities. Here, we address the limited capability of current paper and flexible material-based platforms by integrating cellulose paper and flexible polyester films as diagnostic biosensing materials with various detection modalities through the development and validation of new widely applicable electrical and optical sensing mechanisms using antibodies and peptides. By incorporating these different detection modalities, we present selective and accurate capture and detection of multiple biotargets including viruses (Human Immunodeficieny Virus-1), bacteria (Escherichia coli and Staphylococcus aureus), and cells (CD4+ T lymphocytes) from fingerprick volume equivalent of multiple biological specimens such as whole blood, plasma, and peritoneal dialysis effluent with clinically relevant detection and sensitivity.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351531/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:14351247
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)